Sunitinib versus dacarbazine as first-line treatment in patients with metastatic uveal melanoma

被引：0
|
作者：
Sacco, Joseph J.
Nathan, Paul D.
Danson, Sarah
Lorigan, Paul
Nicholson, Steve
Ottensmeier, Christian
Corrie, Philippa
Steven, Neil
Goodman, Andrew
Larkin, James M. G.
Evans, T. R. Jeffry
Kumar, Satish
Coupland, Sarah E.
Silcocks, Paul
Marshall, Ernie
机构：
[1] Clatterbridge Canc Ctr, Clatterbridge, Merseyside, England
[2] Mt Vernon Canc Ctr, Northwood, Middx, England
[3] Weston Pk Hosp, Canc Res Ctr, Sheffield, S Yorkshire, England
[4] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[5] Charing Cross Hosp, London, England
[6] Southampton Univ Hosp NHS Fdn Trust, Southampton, Hants, England
[7] Addenbrookes Hosp, Ctr Oncol, Cambridge, England
[8] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
[9] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England
[10] Royal Marsden Hosp NHS Fdn Trust, London, England
[11] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[12] Velindre Canc Ctr, Cardiff, S Glam, Wales
[13] Univ Liverpool, Dept Mol & Clin Canc Med, Inst Translat Med, Liverpool L69 3BX, Merseyside, England
[14] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9031
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Pazopanib or Sunitinib? cost-utility analysis of pazopanib versus sunitinib in the first-line treatment of metastatic renal cell carcinoma in Jordan
    Al-Rabayah, Abeer A.
    Sawalha, Razan
    Al Froukh, Rawan Fawzi
    Al-Bawab, Rand
    Jaddoua, Saad M.
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2021, 12 (04) : 566 - 573
  • [22] Continuous temozolomide (TMZ) monotherapy as first-line treatment in patients with metastatic melanoma (MM)
    del Pozo, N.
    Blasco, A.
    Camps, C.
    Caballero, C.
    Estevez Garcia, P.
    Jantus, E.
    Marin, S.
    Oliver, V.
    Berrocal, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [23] EFFICACY AND SAFETY OF SUNITINIB AS FIRST-LINE TREATMENT IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: SYSTEMATIC REVIEW
    Huerfano, C.
    NinoNino, C. P.
    Davila, F.
    Reyes, J. M.
    Diaz, J. A.
    VALUE IN HEALTH, 2016, 19 (03) : A169 - A169
  • [24] Imatinib Escalation or Sunitinib Treatment After First-line Imatinib in Metastatic Gastrointestinal Stromal Tumor Patients
    Hsu, Chih-Chieh
    Wu, Chiao-En
    Chen, Jen-Shi
    Tseng, Jeng-Hwei
    Chiang, Kun-Chun
    Liu, Yu-Yin
    Tsai, Chun-Yi
    Cheng, Chi-Tung
    Chen, Tsung-Wen
    Jan, Yi-Yin
    Yeh, Ta-Sen
    Chen, Yen-Yang
    Yeh, Chun-Nan
    ANTICANCER RESEARCH, 2014, 34 (09) : 5029 - 5036
  • [25] CLINICAL OUTCOMES OF AXITINIB VERSUS SUNITINIB AS A FIRST-LINE THERAPY FOR METASTATIC RENAL CELL CARCINOMA IN JAPANESE PATIENTS
    Kiso, Yusuke
    Inoue, Takamitsu
    Nara, Taketoshi
    Kanda, Sohei
    Numakura, Kazuyuki
    Tsuruta, Hiroshi
    Saito, Mitsuru
    Narita, Shintaro
    Satoh, Shigeru
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2018, 199 (04): : E874 - E874
  • [26] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Vazquez, Sergio
    Leon, Luis
    Fernandez, Ovidio
    Lazaro, Martin
    Grande, Enrique
    Aparicio, Luis
    ADVANCES IN THERAPY, 2012, 29 (03) : 202 - 217
  • [27] Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
    Sergio Vázquez
    Luis León
    Ovidio Fernández
    Martín Lázaro
    Enrique Grande
    Luis Aparicio
    Advances in Therapy, 2012, 29 : 202 - 217
  • [28] Plitidepsin (APL) alone or with dacarbazine (DTIC) as first-line treatment for advanced unresectable melanoma (AUM)
    Plummer, E. R.
    Lorigan, P.
    Hayward, L.
    Jassem, J.
    Demidov, L.
    Moiseyenko, V.
    Soriano, V.
    Chmielowska, E.
    Prados, R.
    Szyldergemajn, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Choice of first-line therapy in metastatic melanoma
    Gibney, Geoffrey T.
    Atkins, Michael B.
    CANCER, 2019, 125 (05) : 666 - 669
  • [30] Immunotherapy for metastatic melanoma—from little benefit to first-line treatment
    Christiane G. Mutz-Rabl
    Peter Koelblinger
    Lukas Koch
    memo - Magazine of European Medical Oncology, 2023, 16 : 108 - 112
12345